Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.
Search results for: Total knee replacement
First ARHP ‘Best of the Meeting’ Highlights Sleep Research, Osteoporosis Screening, More
“The line between ACR and ARHP sessions has totally blurred,” said Donah Zack Crawford, MA, during the presentation, “Highlights from the 2011 ARHP Sessions,” here at the 2011 ACR/ARHP Annual Scientific Meeting held in Chicago in November 2011.
Information on New Drug Approvals and Medication Safety
Rheumatology-related drug safety, approvals, and what’s in the pipeline.
What You Need to Know about ACOs
Rheumatologists may need to speak up to get a place in these new healthcare groups
Drug Updates
Information on new approvals and medication safety
Drug UPDATES
Information on New Approvals and Medication Safety
The DMOAD Dream a Generation Later
Few effective treatments for OA have been developed, and the approach to clinical trials might need modifications
Omeract How to Get into the “Act”
Meet this international organization that focuses on rheumatology outcome measures
Sex Differences & Rheumatoid Arthritis
The beliefs versus the data
Hypercoagulable States in Rheumatic Disease
Prevention and management strategies continue to evolve